{Reference Type}: Journal Article
{Title}: Exosomes in asthma: Underappreciated contributors to the pathogenesis and novel therapeutic tools.
{Author}: Kanannejad Z;Arab S;Soleimanian S;Mazare A;Kheshtchin N;
{Journal}: Immun Inflamm Dis
{Volume}: 12
{Issue}: 6
{Year}: 2024 Jun
{Factor}: 2.493
{DOI}: 10.1002/iid3.1325
{Abstract}: <B>OBJECTIVE: </B>Asthma, a chronic inflammatory disease with diverse pathomechanisms, presents challenges in developing personalized diagnostic and therapeutic approaches. This review aims to provide a comprehensive overview of the role of exosomes, small extracellular vesicles, in asthma pathophysiology and explores their potential as diagnostic biomarkers and therapeutic tools.<BR><B>METHODS: </B>A literature search was conducted to identify recent studies investigating the involvement of exosomes in asthma. The retrieved articles were analyzed to extract relevant information on the role of exosomes in maintaining lung microenvironment homeostasis, regulating inflammatory responses, and their diagnostic and therapeutic potential for asthma.<BR><B>RESULTS: </B>Exosomes secreted by various cell types, have emerged as crucial mediators of intercellular communication in healthy and diseased conditions. Evidence suggest that exosomes play a significant role in maintaining lung microenvironment homeostasis and contribute to asthma pathogenesis by regulating inflammatory responses. Differential exosomal content between healthy individuals and asthmatics holds promise for the development of novel asthma biomarkers. Furthermore, exosomes secreted by immune and nonimmune cells, as well as those detected in biofluids, demonstrate potential in promoting or regulating immune responses, making them attractive candidates for designing new treatment strategies for inflammatory conditions such as asthma.<BR><B>CONCLUSIONS: </B>Exosomes, with their ability to modulate immune responses and deliver therapeutic cargo, offer potential as targeted therapeutic tools in asthma management. Further research and clinical trials are required to fully understand the mechanisms underlying exosome-mediated effects and translate these findings into effective diagnostic and therapeutic strategies for asthma patients.